| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |